E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/16/2006 in the Prospect News Biotech Daily.

Biosense Webster gains right to distribute Siemens' ultrasound cardiac catheters

By Angela McDaniels

Seattle, March 16 - Biosense Webster Inc. and Siemens Medical Solutions said they have formed a strategic alliance that gives Biosense Webster exclusive worldwide rights to distribute Siemens' Acuson AcuNav ultrasound cardiac catheters to electrophysiologists.

Siemens will continue to distribute the catheters to interventional cardiologists through its own sales force, according to a company news release.

Siemens' AcuNav catheters provide real-time ultrasound imaging of blood flow and other catheters inside the heart to aid in diagnosis and cardiac catheterization procedures.

"This agreement provides potential opportunities to assess how AcuNav can be combined with our unique cardiac mapping and navigation systems," Biosense Webster president Roy Tanaka said in the release.

The two companies agreed to co-develop future products.

"Biosense Webster's expertise in the field of electrophysiology and Siemens' leadership in ultrasound is an ideal combination to help develop future technologies," Vivek Y. Reddy of the Massachusetts General Hospital in Boston said in the release.

Biosense Webster is a Johnson & Johnson company based in Diamond Bar, Calif., that makes diagnostic, therapeutic and mapping tools.

Siemens Medical Solutions, a subsidiary of Siemens AG, is based in Malvern, Pa., and supplies medical technologies, information systems, management consulting and support services to the health-care industry.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.